부산대학교 도서관

Andrews, Miles C; Berry, Donald A; Block, Matthew S; Boland, Genevieve M; Bollin, Kathryn B; Carlino, Matteo S; Carvajal, Richard D; Cohen, Jonathan; Davar, Diwakar; Delman, Keith A; Dummer, Reinhard; Farwell, Michael D; Fisher, David E; Fusi, Alberto; Glitza, Isabella C; de Gruijl, Tanja D; Gyorki, David E; Hauschild, Axel; Hieken, Tina J; Larkin, James; Lawson, David H; Lebbe, Celeste; Lee, Jeffrey E; Lowe, Michael C; Luke, Jason J; McArthur, Grant A; McDermott, David F; McQuade, Jennifer L; Mitchell, Tara C; Petrella, Teresa M; Prieto, Peter A; Puzanov, Igor; Robert, Caroline; Salama, April K; Sandhu, Shaneen; Schadendorf, Dirk; Shoushtari, Alexander N; Sosman, Jeffrey A; Swetter, Susan M; Tanabe, Ken K; Turajlic, Samra; Tyler, Douglas S; Woodman, Scott E; Wright, Frances C; Zager, Jonathan S; Amaria, Rodabe N ; Menzies, Alexander M ; Burton, Elizabeth M ; Scolyer, Richard A ; Tetzlaff, Michael T ; Antdbacka, Robert ; Ariyan, Charlotte ; Bassett, Roland ; Carter, Brett ; Daud, Adil ; Faries, Mark ; Fecher, Leslie A ; Flaherty, Keith T ; Gershenwald, Jeffrey E ; Hamid, Omid ; Hong, Angela ; Kirkwood, John M ; Lo, Serigne ; Margolin, Kim ; Messina, Jane ; Postow, Michael A ; Rizos, Helen ; Ross, Merrick I ; Rozeman, Elisa A ; Saw, Robyn P M ; Sondak, Vernon ; Sullivan, Ryan J ; Taube, Janis M ; Thompson, John F ; van de Wiel, Bart A ; Eggermont, Alexander M ; Davies, Michael A ; Ascierto, Paolo A ; Spillane, Andrew J ; van Akkooi, Alexander C J ; Wargo, Jennifer A ; Blank, Christian U ; Tawbi, Hussein A ; Long, Georgina V

In The Lancet Oncology July 2019 20(7):e378-e389

Amaria, Rodabe N ; Prieto, Peter A ; Tetzlaff, Michael T ; Reuben, Alexandre ; Andrews, Miles C ; Ross, Merrick I ; Glitza, Isabella C ; Cormier, Janice ; Hwu, Wen-Jen ; Tawbi, Hussein A ; Patel, Sapna P ; Lee, Jeffrey E ; Gershenwald, Jeffrey E ; Spencer, Christine N ; Gopalakrishnan, Vancheswaran ; Bassett, Roland ; Simpson, Lauren ; Mouton, Rosalind ; Hudgens, Courtney W ; Zhao, Li ; Zhu, Haifeng ; Cooper, Zachary A ; Wani, Khalida ; Lazar, Alexander ; Hwu, Patrick ; Diab, Adi ; Wong, Michael K ; McQuade, Jennifer L ; Royal, Richard ; Lucci, Anthony ; Burton, Elizabeth M ; Reddy, Sangeetha ; Sharma, Padmanee ; Allison, James ; Futreal, Phillip A ; Woodman, Scott E ; Davies, Michael A ; Wargo, Jennifer A

In The Lancet Oncology February 2018 19(2):181-193

Glitza, Isabella C ; Rohlfs, Michelle ; Guha-Thakurta, Nandita ; Bassett, Roland L, Jr ; Bernatchez, Chantale ; Diab, Adi ; Woodman, Scott E ; Yee, Cassian ; Amaria, Rodabe N ; Patel, Sapna P ; Tawbi, Hussein ; Wong, Michael ; Hwu, Wen-Jen ; Hwu, Patrick ; Heimberger, Amy ; McCutcheon, Ian E ; Papadopoulos, Nicholas ; Davies, Michael A

In ESMO Open 2018 3(1)

Hasanov M; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA.; Kiany S; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Forget MA; Cell Therapy Manufacturing Center, Houston, TX, USA.; Bassett R; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Davies MA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Diab A; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Gershenwald JE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Glitza IC; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lee JE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lucci A; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; McQuade JL; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Patel SP; Department of Medical Oncology, University of Colorado, Aurora, CO.; Ross MI; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Tawbi HA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Wargo JA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Wong MK; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Bernatchez C; Cell Therapy Manufacturing Center, Houston, TX, USA.; Hwu P; Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, USA.; Haymaker C; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Amaria RN; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2162-402X (Electronic) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: MEDLINE

Dimitriou F; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Wu X; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Nagarajan P; Department of Anatomical Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Glitza IC; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Zhao L; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Ning J; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Patel SP; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Division of Medical Oncology, Department of Medicine, University of Colorado, Aurora, CO, USA.; Wargo JA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Futreal A; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Woodman S; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; McQuade JL; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Esmaeli B; Orbital Oncology & Ophthalmic Plastic Surgery, Department of Plastic Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. besmaeli66@gmail.com.

Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE

Mattei J; Department of Hematology Oncology, UT Health Science Center San Antonio, San Antonio.; Ruitao L; Department of Biostatistics.; Davies MA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Wong MK; Department of Hematology Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, New York.; Diab A; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Haydu LE; Department of Biostatistics.; Patel SP; Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.; Amaria RN; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; McQuade JL; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Tawbi H; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Burton EM; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Glitza IC; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 9109623 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1473-5636 (Electronic) Linking ISSN: 09608931 NLM ISO Abbreviation: Melanoma Res Subsets: MEDLINE

Chen PL; Roh W; Reuben A; Cooper ZA; Spencer CN; Prieto PA; Miller JP; Bassett RL; Gopalakrishnan V; Wani K; De Macedo MP; Austin-Breneman JL; Jiang H; Chang Q; Reddy SM; Chen WS; Tetzlaff MT; Broaddus RJ; Davies MA; Gershenwald JE; Haydu L; Lazar AJ; Patel SP; Hwu P; Hwu WJ; Diab A; Glitza IC; Woodman SE; Vence LM; Wistuba II; Amaria RN; Kwong LN; Prieto V; Davis RE; Ma W; Overwijk WW; Sharpe AH; Hu J; Futreal PA; Blando J; Sharma P; Allison JP; Chin L; Wargo JA

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE; In Process

Kimchi G; Department of Neurosurgery, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Varela S; Department of Neurosurgery, Baylor College of Medicine, Houston, TX 77030, USA.; Zuluaga-Garcia JP; Department of Neurosurgery, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Call-Orellana F; Department of Neurosurgery, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Ramirez Ferrer E; Department of Neurosurgery, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Andrade de Almeida RA; Department of Neurosurgery, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Gubbiotti MA; Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Glitza IC; Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Bishop AJ; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Grant JD; Department of Radiation Oncology, Intermountain Health, Murray, UT 84107, USA.; North RY; Department of Neurosurgery, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Alvarez-Breckenridge CA; Department of Neurosurgery, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Rhines LD; Department of Neurosurgery, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Tatsui CE; Department of Neurosurgery, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101606588 Publication Model: Electronic Cited Medium: Print ISSN: 2077-0383 (Print) Linking ISSN: 20770383 NLM ISO Abbreviation: J Clin Med Subsets: PubMed not MEDLINE

Phillips, Suzanne; John, Ida; Bassett Jr, Roland; Rohlfs, Michelle; Iqbal, Masood; Richard, Jessica; McCutcheon, Ian E; Ferguson, Sherise D; Weinberg, Jeffrey S; Morad, Golnaz; Amaria, Rodabe N; McQuade, Jennifer L; Ikeguchi, Alexandra P; Tawbi, Hussein A; Davies, Michael A; Burton, Elizabeth M; Glitza, Isabella C

Neurooncol Adv

Burton EM; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.; Milton DR; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX.; Tetzlaff MT; Department of Pathology, The University of California San Francisco, San Francisco, CA.; Wani K; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Ross MI; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Postow MA; Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY.; Lazcano R; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Glitza IC; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Wong MK; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Patel SP; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.; University of Colorado Cancer Center, Aurora, CO.; Diab A; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Gershenwald JE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.; McQuade JL; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Betof Warner A; Stanford University School of Medicine, Stanford University, Stanford, CA.; Prieto VG; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Lee JE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Goepfert RP; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX.; Fisher SB; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Song A; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Malke J; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Simon JM; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Ariyan C; Department of Surgical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.; Torres-Cabala CA; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Davies MA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Lazar A; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Wargo JA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Tawbi HA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Amaria RN; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

Glitza IC; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Seo YD; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Spencer CN; Parker Institute for Cancer Immunotherapy, San Francisco, California.; Wortman JR; Seres Therapeutics, Cambridge, Massachusetts.; Burton EM; Strategic Translational Research Initiative Development, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Alayli FA; Parker Institute for Cancer Immunotherapy, San Francisco, California.; Loo CP; Parker Institute for Cancer Immunotherapy, San Francisco, California.; Gautam S; Parker Institute for Cancer Immunotherapy, San Francisco, California.; Damania A; Platform for Innovative Microbiome and Translational Research, Moon Shots Program, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Densmore J; Parker Institute for Cancer Immunotherapy, San Francisco, California.; Fairchild J; Parker Institute for Cancer Immunotherapy, San Francisco, California.; Portage Biotech, Westport, Connecticut.; Cabanski CR; Parker Institute for Cancer Immunotherapy, San Francisco, California.; Wong MC; Platform for Innovative Microbiome and Translational Research, Moon Shots Program, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Peterson CB; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Weiner B; Seres Therapeutics, Cambridge, Massachusetts.; Hicks N; Seres Therapeutics, Cambridge, Massachusetts.; Aunins J; Seres Therapeutics, Cambridge, Massachusetts.; McChalicher C; Seres Therapeutics, Cambridge, Massachusetts.; Walsh E; Seres Therapeutics, Cambridge, Massachusetts.; Tetzlaff MT; Department of Pathology, University of California San Francisco, San Francisco, California.; Hamid O; Cutaneous Oncology, The Angeles Clinic and Research Institute, A Cedars-Sinai Affiliate, Los Angeles, California.; Ott PA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Boland GM; Division of Surgical Oncology, Department of Surgery, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Sullivan RJ; Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.; Grossmann KF; Providence Cancer Institute Franz Clinic, Portland, Oregon.; Ajami NJ; Platform for Innovative Microbiome and Translational Research, Moon Shots Program, The University of Texas MD Anderson Cancer Center, Houston, Texas.; LaVallee T; Parker Institute for Cancer Immunotherapy, San Francisco, California.; Coherus BioSciences, Redwood City, California.; Henn MR; Seres Therapeutics, Cambridge, Massachusetts.; Tawbi HA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Wargo JA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE

Starling, Caroline T; Messer, Alison A; Kleiman, Anne; McQuade, Jennifer L; Glitza, Isabella C; Torres-Cabala, Carlos Antonio; Heberton, Meghan

Dermatology Online Journal, vol 28, iss 2

Spencer CN; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; McQuade JL; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Gopalakrishnan V; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; McCulloch JA; Laboratory of Integrative Cancer Immunology, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD 20892, USA.; Vetizou M; Laboratory of Integrative Cancer Immunology, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD 20892, USA.; Cogdill AP; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Khan MAW; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Zhang X; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; White MG; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Peterson CB; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Wong MC; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Morad G; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Rodgers T; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Badger JH; Laboratory of Integrative Cancer Immunology, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD 20892, USA.; Helmink BA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Andrews MC; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Department of Medicine, Monash University, Melbourne, VIC 3004, Australia.; Rodrigues RR; Frederick National Laboratory for Cancer Research, and Microbiome and Genetics Core, Laboratory of Integrative Cancer Immunology, CCR, NCI, NIH, Bethesda, MD 20852, USA.; Morgun A; Department of Pharmaceutical Science, Oregon State University, Corvallis, OR 97331, USA.; Kim YS; Nutritional Science Research Group, Division of Cancer Prevention, NCI, NIH, Rockville, MD 20850, USA.; Roszik J; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Hoffman KL; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA.; Zheng J; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Zhou Y; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Medik YB; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Kahn LM; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; MD Anderson University of Texas Health Graduate School, Houston, TX 77030, USA.; Johnson S; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Hudgens CW; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Wani K; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Gaudreau PO; Canadian Cancer Trials Group and Department of Oncology, Queen's University, Kingston, ON K7L 3N6, Canada.; Harris AL; Center for Co-Clinical Trials, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Jamal MA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Baruch EN; Department of Internal Medicine, The University of Texas Health Science Center, Houston, TX 77030, USA.; Perez-Guijarro E; Laboratory of Cancer Biology and Genetics, CCR, NCI, NIH, Bethesda, MD 20892, USA.; Day CP; Laboratory of Cancer Biology and Genetics, CCR, NCI, NIH, Bethesda, MD 20892, USA.; Merlino G; Laboratory of Cancer Biology and Genetics, CCR, NCI, NIH, Bethesda, MD 20892, USA.; Pazdrak B; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Lochmann BS; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Szczepaniak-Sloane RA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Arora R; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Anderson J; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Zobniw CM; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Posada E; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Sirmans E; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Simon J; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Haydu LE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Burton EM; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Wang L; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Dang M; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Clise-Dwyer K; Advanced Cytometry and Sorting Facility at South Campus, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Department of Hematopoietic Biology and Malignancy, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Schneider S; Advanced Cytometry and Sorting Facility at South Campus, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Chapman T; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Anang NAS; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Duncan S; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Toker J; Department of Neurosurgery, Harvard University, Cambridge, MA 02138, USA.; Department of Oncology, University of Cambridge, Cambridge CB2 1TN, UK.; Malke JC; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Glitza IC; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Amaria RN; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Tawbi HA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Diab A; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Wong MK; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Patel SP; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Woodman SE; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Davies MA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Ross MI; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Gershenwald JE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Lee JE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Hwu P; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Jensen V; Department of Veterinary Medicine and Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Samuels Y; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, 76100, Israel.; Straussman R; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, 76100, Israel.; Ajami NJ; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Nelson KC; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Nezi L; Dipartimento di Oncologia Sperimentale, Instituto Europeo di Oncologia, Milan, P.I. 08691440153, Italy.; Petrosino JF; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA.; Futreal PA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Lazar AJ; MD Anderson University of Texas Health Graduate School, Houston, TX 77030, USA.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Hu J; Department of Biostatistics, Columbia University, New York, NY 10032, USA.; Jenq RR; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Department of Stem Cell Transplant, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Tetzlaff MT; Departments of Pathology and Dermatology, Dermatopathology and Oral Pathology Unit, University of California San Francisco, San Francisco, CA 94115, USA.; Yan Y; Department of Biostatistics and the Harvard T.H. Chan Microbiome in Public Health Center, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA 02115, USA.; Garrett WS; Department of Molecular Metabolism, T.H. Chan School of Public Health, Harvard University, Boston, MA 02115, USA.; Huttenhower C; Department of Biostatistics and the Harvard T.H. Chan Microbiome in Public Health Center, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA 02115, USA.; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA.; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Harvard Chan Microbiome in Public Health Center, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA.; Sharma P; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Parker Institute for Cancer Immunotherapy, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Watowich SS; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Allison JP; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Parker Institute for Cancer Immunotherapy, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Cohen L; Department of Palliative, Rehabilitation, and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Trinchieri G; Laboratory of Integrative Cancer Immunology, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD 20892, USA.; Daniel CR; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Wargo JA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-9203 (Electronic) Linking ISSN: 00368075 NLM ISO Abbreviation: Science Subsets: MEDLINE

Johnson, Daniel H; Zobniw, Chrystia M; Trinh, Van A; Ma, Junsheng; Bassett, Roland L; Abdel-Wahab, Noha; Anderson, Jaime; Davis, Jennifer E; Joseph, Jocelyn; Uemura, Marc; Noman, Ali; Abu-Sbeih, Hamzah; Yee, Cassian; Amaria, Rodabe; Patel, Sapna; Tawbi, Hussein; Glitza, Isabella C; Davies, Michael A; Wong, Michael K; Woodman, Scott; Hwu, Wen-Jen; Hwu, Patrick; Wang, Yinghong; Diab, Adi

Journal for ImmunoTherapy of Cancer. October 11, 2018, Vol. 6 Issue 1

Messer A; Department of Dermatology, University of Texas MD Anderson Cancer Center, Houston, TX Department of Dermatology, McGovern Medical School, Houston, TX. Alison.M.Garner@uth.tmc.edu.; Drozd B; Glitza IC; Lu H; Patel AB

Publisher: Dermsquared Country of Publication: United States NLM ID: 9610776 Publication Model: Electronic Cited Medium: Internet ISSN: 1087-2108 (Electronic) Linking ISSN: 10872108 NLM ISO Abbreviation: Dermatol Online J Subsets: MEDLINE

Glitza IC; Department of Melanoma Medical Oncology, UT MD Anderson Cancer Center, Houston, TX, USA.; Smalley KSM; Melanoma Research Center of Excellence, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; Brastianos PK; Department of Hematology/Oncology, Massachusetts General Hospital, Boston, MA.; Davies MA; Department of Melanoma Medical Oncology, UT MD Anderson Cancer Center, Houston, TX, USA.; McCutcheon I; Department of Neurosurgery, UT MD Anderson Cancer Center, Houston, TX, USA.; Liu JKC; Department of Neuro-Oncology & Tumor Biology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; Ahmed KA; Department of Radiation Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; Arrington JA; Head of Neuroradiology Section, Department of Radiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; Evernden BR; Department of Neuro-Oncology & Tumor Biology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; Smalley I; Department of Tumor Biology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; Eroglu Z; Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; Khushalani N; Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; Margolin K; Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, CA, USA.; Kluger H; Department of Medical Oncology, Yale Cancer Center, New Haven, CT, USA.; Atkins MB; Department of Medical Oncology, Georgetown University Medical Center, Washington, DC, USA.; Tawbi H; Department of Melanoma Medical Oncology, UT MD Anderson Cancer Center, Houston, TX, USA.; Boire A; Department of Neuro-Oncology, Memorial Sloan Kettering, New York, NY, USA.; Forsyth P; Department of Neuro-Oncology & Tumor Biology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.

Publisher: Blackwell Munksgaard Country of Publication: England NLM ID: 101318927 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1755-148X (Electronic) Linking ISSN: 17551471 NLM ISO Abbreviation: Pigment Cell Melanoma Res Subsets: MEDLINE

Holbrook K; The University of Texas MD Anderson Cancer Center, Houston, Texas.; Lutzky J; Mount Sinai Comprehensive Cancer Center, Miami Beach, Florida.; Davies MA; The University of Texas MD Anderson Cancer Center, Houston, Texas.; Davis JM; Levine Cancer Institute, Atrium Health, Charlotte, North Carolina.; Glitza IC; The University of Texas MD Anderson Cancer Center, Houston, Texas.; Amaria RN; The University of Texas MD Anderson Cancer Center, Houston, Texas.; Diab A; The University of Texas MD Anderson Cancer Center, Houston, Texas.; Patel SP; The University of Texas MD Anderson Cancer Center, Houston, Texas.; Amin A; Levine Cancer Institute, Atrium Health, Charlotte, North Carolina.; Tawbi H; The University of Texas MD Anderson Cancer Center, Houston, Texas.

Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

Pires da Silva I; Melanoma Institute Australia and The University of Sydney, Sydney, New South Wales, Australia.; Glitza IC; The University of Texas MD Anderson Cancer Center, Houston, Texas.; Haydu LE; The University of Texas MD Anderson Cancer Center, Houston, Texas.; Johnpulle R; Vanderbilt University Medical Center, Nashville, Tennessee.; Banks PD; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Grass GD; H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.; Goldinger SMA; University Hospital Zurich, Zurich, Switzerland.; Smith JL; Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, New South Wales, Australia.; Everett AS; University of Alabama at Birmingham, Birmingham, Alabama.; Koelblinger P; Paracelsus Medical University, Salzburg, Austria.; Roberts-Thomson R; The Queen Elizabeth Hospital, Woodville South, South Australia, Australia.; Millward M; School of Medicine, University of Western Australia, Perth, Western Australia, Australia.; Department of Medical Oncology, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia.; Atkinson VG; Princess Alexandra Hospital and Greenslopes Private Hospital, University of Queensland, Brisbane, Queensland, Australia.; Guminski A; Melanoma Institute Australia and The University of Sydney, Sydney, New South Wales, Australia.; Royal North Shore and Mater Hospitals, Sydney, New South Wales, Australia.; Kapoor R; Melanoma Institute Australia and The University of Sydney, Sydney, New South Wales, Australia.; Conry RM; University of Alabama at Birmingham, Birmingham, Alabama.; Carlino MS; Melanoma Institute Australia and The University of Sydney, Sydney, New South Wales, Australia.; Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, New South Wales, Australia.; Wang W; Melanoma Institute Australia and The University of Sydney, Sydney, New South Wales, Australia.; Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, New South Wales, Australia.; Shackleton MJ; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Central Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia.; Department of Oncology, Alfred Health, Melbourne, Victoria, Australia.; Eroglu Z; H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.; Lo S; Melanoma Institute Australia and The University of Sydney, Sydney, New South Wales, Australia.; Hong AM; Melanoma Institute Australia and The University of Sydney, Sydney, New South Wales, Australia.; Long GV; Melanoma Institute Australia and The University of Sydney, Sydney, New South Wales, Australia.; Royal North Shore and Mater Hospitals, Sydney, New South Wales, Australia.; Johnson DB; Vanderbilt University Medical Center, Nashville, Tennessee.; Menzies AM; Melanoma Institute Australia and The University of Sydney, Sydney, New South Wales, Australia.; Royal North Shore and Mater Hospitals, Sydney, New South Wales, Australia.

Publisher: Blackwell Munksgaard Country of Publication: England NLM ID: 101318927 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1755-148X (Electronic) Linking ISSN: 17551471 NLM ISO Abbreviation: Pigment Cell Melanoma Res Subsets: MEDLINE

Schvartsman G; Centro de Oncologia e Hematologia - Hospital Israelita Albert Einstein, 627 Albert Einstein Avenue, São Paulo, SP 05653-120, Brazil.; Taranto P; Department of Medical Oncology, Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.; Glitza IC; Department of Melanoma Medical Oncology, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.; Agarwala SS; Department of Hematology and Oncology, and Temple University, Easton, PA, USA.; Atkins MB; Department of Oncology, Georgetown University School of Medicine, Georgetown-Lombardi Comprehensive Cancer Center, Washington, DC, USA.; Buzaid AC; Department of Medical Oncology, Hospital Israelita Albert Einstein, São Paulo, SP, Brazila and Department of Medical Oncology, A Beneficência Portuguesa de São Paulo - BP, São Paulo, SP, Brazil.

Publisher: Sage Country of Publication: England NLM ID: 101510808 Publication Model: eCollection Cited Medium: Print ISSN: 1758-8340 (Print) Linking ISSN: 17588340 NLM ISO Abbreviation: Ther Adv Med Oncol Subsets: PubMed not MEDLINE

Eroglu Z; Moffitt Cancer Center, Tampa, Florida.; Holmen SL; University of Utah Health Sciences Center, Salt Lake City, Utah.; Chen Q; The Wistar Institute, Philadelphia, Pennsylvania.; Khushalani NI; Moffitt Cancer Center, Tampa, Florida.; Amaravadi R; The University of Pennsylvania, Philadelphia, Pennsylvania.; Thomas R; Stanford University, Palo Alto, California.; Ahmed KA; Moffitt Cancer Center, Tampa, Florida.; Tawbi H; MD Anderson Cancer Center, Houston, Texas.; Chandra S; Northwestern University, Chicago, Illinois.; Markowitz J; Moffitt Cancer Center, Tampa, Florida.; Smalley I; Moffitt Cancer Center, Tampa, Florida.; Liu JKC; Moffitt Cancer Center, Tampa, Florida.; Chen YA; Moffitt Cancer Center, Tampa, Florida.; Najjar YG; University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.; Karreth FA; Moffitt Cancer Center, Tampa, Florida.; Abate-Daga D; Moffitt Cancer Center, Tampa, Florida.; Glitza IC; MD Anderson Cancer Center, Houston, Texas.; Sosman JA; Northwestern University, Chicago, Illinois.; Sondak VK; Moffitt Cancer Center, Tampa, Florida.; Bosenberg M; Yale University, New Haven, Connecticut.; Herlyn M; The Wistar Institute, Philadelphia, Pennsylvania.; Atkins MB; Georgetown University Cancer Center, Washington, District of Columbia.; Kluger H; Yale University, New Haven, Connecticut.; Margolin K; City of Hope, Duarte, California.; Forsyth PA; Moffitt Cancer Center, Tampa, Florida.; Davies MA; MD Anderson Cancer Center, Houston, Texas.; Smalley KSM; Moffitt Cancer Center, Tampa, Florida.

Publisher: Blackwell Munksgaard Country of Publication: England NLM ID: 101318927 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1755-148X (Electronic) Linking ISSN: 17551471 NLM ISO Abbreviation: Pigment Cell Melanoma Res Subsets: MEDLINE